Research Topics
| G HolzerSummaryAffiliation: Medical University of Vienna Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized studyG Holzer
Division of Special and Environmental Dermatology, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Br J Dermatol 153:626-34. 2005..For many years topical progesterone has been prescribed by gynaecologists as an antiageing and skin-firming treatment, without any clinical scientific evidence of its effects, tolerability and safety when applied to skin...- Photoepilation with variable pulsed light in non-facial body areas: evaluation of efficacy and safetyG Holzer
Department of Dermatology, Division of Special and Environmental Dermatology, Mxedical University Vienna, Vienna, Austria
J Eur Acad Dermatol Venereol 24:518-23. 2010..6%) or coarse (9.4%) body hair. Minimum follow-up period was 12 months (mean: 13.14 +/- 2.38). Treatment parameters were as follows: number x duration of micropulses: 15 x 5-15 x 7 ms, pulse delay: 1-8 ms, fluence: 30-45 J/cm(2)... - Evaluation of safety and efficacy of variable pulsed light in the treatment of unwanted hair in 77 volunteersH Nahavandi
Department of Dermatology, Division of Special and Environmental Dermatology, Medical University of Vienna, Vienna, Austria
J Eur Acad Dermatol Venereol 22:311-5. 2008..The minimum follow-up time after the last treatment was 9 months (mean: 12.74 +/- 2.87 months)... - Soluble p185(HER-2) in patients with malignant bone tumoursG Holzer
Department of Orthopaedics, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
Pediatr Blood Cancer 44:163-6. 2005..This study was initiated to test the hypothesis that soluble p185(HER-2) could be of value as a diagnostic or predictive marker for patients with malignant bone tumours... - [Bisphosphonates for malignant bone tumors]G Holzer
Universitätsklinik für Orthopädie, Medizinische Universitat, Wien, Osterreich
Orthopade 38:316, 318-23. 2009..In a number of cases, the dosing regime must be adjusted according to renal function and baseline creatinine clearance. This paper reviews the current evidence-based use of BPs in solid tumors and the recommendations for treatment... - Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumorsG Holzer
Department of Orthopaedics, University of Vienna, Vienna General Hospital, Vienna, Austria
Med Pediatr Oncol 36:601-4. 2001..The aim of the present study was to compare preoperative serum VEGF levels of patients having malignant bone tumors with healthy controls to identify serum VEGF levels as a tumor marker... - Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumoursG Holzer
Department of Orthopaedics, University of Vienna, Vienna General Hospital, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Anticancer Res 23:3057-9. 2003..To determine serum levels of TNF-beta and soluble TNF-R in patients with primary highly malignant bone tumours... - 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trialS Tzaneva
Division of Special and Environmental Dermatology, Medical University of Vienna, Vienna, Austria
Br J Dermatol 162:655-60. 2010..Ultraviolet (UV) A1 and psoralen plus UVA (PUVA) are effective treatment options for severe atopic dermatitis (AD); however, their relative efficacy has not yet been determined in a head-to-head study... - Bone mineral density in long-term survivors of highly malignant osteosarcomaG Holzer
Department of Orthopaedics, Vienna General Hospital, Vienna, Austria
J Bone Joint Surg Br 85:231-7. 2003..Ten patients were osteoporotic, 21 osteopenic and 17 normal according to the WHO definition. Eighteen patients suffered fractures after receiving chemotherapy and all had significantly lower levels of BMD for all the sites measured...